Mosegor 0,5 mg/10 ml solución oral
Prescription request online
A doctor will review your case and decide whether a prescription is medically appropriate.
Talk to a doctor about this medicine
Discuss your symptoms and possible next steps in a quick online consultation.
How to use MOSEGOR 0.5 mg/10 ml ORAL SOLUTION
Contents of the leaflet
- Introduction
- What is Mosegor and what is it used for
- What you need to know before taking Mosegor
- How to take Mosegor
- Possible side effects
- Storage of Mosegor
- Contents of the pack and further information
Introduction
Package Leaflet: Information for the User
Mosegor0.5 mg/10 ml Oral Solution
Pizotifen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the Package Leaflet
- What is Mosegor and what is it used for
- What you need to know before taking Mosegor
- How to take Mosegor
- Possible side effects
- Storage of Mosegor
- Contents of the pack and further information
1. What is Mosegor and what is it used for
The active substance of Mosegor is pizotifen, which has an appetite-stimulating effect that promotes weight gain in patients with low body weight (whose appetite has been reduced or lost).
Mosegor is used for the treatment of loss of appetite in patients with low body weight as a complement to the treatment of the disease that causes weight loss.
Not sure if this medicine is right for you?
Discuss your symptoms and treatment with a doctor online.
2. What you need to know before taking Mosegor
Follow your doctor's instructions carefully. These may differ from the general information included in this leaflet.
Do not take Mosegor
- if you are allergic (hypersensitive) to pizotifen or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Tell your doctor if you have or have had any of these conditions:
- if you have liver problems. This medicine has been associated with some cases of abnormal liver function test results. You may not notice any symptoms, but if you notice that your skin or the whites of your eyes turn yellow, your urine darkens, or you experience nausea, vomiting, and fatigue, tell your doctor immediately. Your doctor may ask you to have a blood test to check and monitor liver function and may tell you to stop treatment if the problem is severe.
If you experience the symptoms described above while taking Mosegor, tell your doctor immediately.
- if you have vision problems due to increased pressure in the eye (signs of narrow-angle glaucoma), except if you have been successfully operated on.
- if you have urinary retention (difficulty urinating, as in the case of prostate hypertrophy).
- if you have seizures.
If you are in any of the situations described, tell your doctor before taking the medicine.
Children and adolescents
Mosegor should not be given to children under 2 years of age.
Interaction of Mosegor with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is important that your doctor knows if you are taking:
- Sedatives or hypnotics (tranquilizers, sleeping pills, or medications for anxiety) as they may increase the sedative effects of Mosegor.
- Antihistamines (medicines used against allergies or the common cold) as they may increase the sedative effects of Mosegor.
- Cisapride (a medicine used to treat acidity).
Mosegor with food, drink, and alcohol
Consuming alcohol may increase the sedative effects of this medicine.
Pregnancy and breastfeeding
Pregnancy
Tell your doctor if you are or think you may be pregnant.
Experience with Mosegor in pregnancy is limited, so it should only be used in special circumstances, which your doctor will discuss with you.
Breastfeeding
Do not take the medicine while breastfeeding.
Driving and using machines
This medicine may cause drowsiness, dizziness, and other effects on the brain, so you should drive and use machines with caution. If you feel sleepy, do not drive or perform any activity that requires you to be alert (such as using tools or machines) until you feel well enough to avoid any risk to yourself and others.
Mosegor contains ethanol
- This medicine contains 2% ethanol (alcohol), which corresponds to 200 mg per 10 ml, equivalent to 4 ml of beer or 1.7 ml of wine. This medicine is harmful to people with alcoholism. The alcohol content should be taken into account in the case of pregnant or breastfeeding women, children, and high-risk populations, such as patients with liver disease or epilepsy.
Mosegor contains sucrose
- If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine. It may cause cavities.
Mosegor contains propyl parahydroxybenzoate and methyl parahydroxybenzoate
- May cause allergic reactions (possibly delayed).
Mosegor contains sorbitol
This medicine contains 10 g of sorbitol per 20 ml dose. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult with your doctor before taking this medicine. Sorbitol may cause gastrointestinal upset and a mild laxative effect.
3. How to take Mosegor
Follow your doctor's instructions for taking Mosegor exactly. If you are unsure, consult your doctor or pharmacist again. Do not take a higher dose than your doctor has indicated.
The initial dose in adults is 0.5 mg (10 ml of the solution) per day, which may be gradually increased to 0.5 mg (10 ml of the solution) three times a day.
Use in children (from 2 to 12 years)
Low initial doses will be gradually increased to reach a maintenance dose of 0.025 mg/kg per day. The resulting total dose may be divided into 2 or 3 daily doses, as prescribed by your doctor.
These are the approximate daily doses:
- Children from 2 to 6 years: 5 to 10 ml of solution (0.25 mg to 0.5 mg) in divided doses (split into 2 or 3 doses, as indicated by the doctor). For example, for children 2 years old or 14 kg in weight, 7 ml; for children 3 years old or 16 kg in weight, 8 ml; for children 4 years old or 18 kg in weight, 9 ml; for children 5 years old or 20 kg in weight, 10 ml; for children 6 years old and under 23 kg in weight, 10 ml.
- Children from 6 to 12 years: 10 to 20 ml of solution (0.5 mg to 1 mg) in divided doses. For example, for children 6 years old or over 23 kg in weight, 11 ml; for children 7 years old or 26 kg in weight, 13 ml; for children 8 years old or 30 kg in weight, 15 ml; for children 9 years old or 35 kg in weight, 17 ml; for children 10 to 12 years old or approximately 40 kg in weight, 20 ml.
In adolescents over 13 years old with a body weight over 40 kg, the same dose as for an adult can be administered, i.e., starting with 0.5 mg per day and gradually increasing the dose to 0.5 mg three times a day.
If you take more Mosegor than you should
If you have accidentally taken too much Mosegor solution, contact your doctor immediately as medical attention may be necessary. You can also call the Toxicology Information Service, phone number 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Mosegor
If you forget to take a dose of Mosegor, take it as soon as possible. If it is only 4 hours or less until the next dose, wait until the scheduled time and take the medicine according to the initial schedule. Do not take a double dose to make up for forgotten doses. If you are unsure, consult your doctor.
If you stop taking Mosegor
Do not change or stop your medication without asking your doctor. Your doctor may recommend gradually reducing the dose before stopping treatment. This is done to avoid worsening your health condition and reduce the risk of withdrawal symptoms such as depression, tremors, nausea, anxiety, feeling unwell, dizziness, sleep disorders, and weight loss.
If you have any doubts about the use of this medicine, ask your doctor or pharmacist.
Started taking the medicine and have questions?
Discuss your symptoms and treatment with a doctor online.
4. Possible side effects
Like all medicines, Mosegor can cause side effects, although not everybody gets them.
These side effects may occur with certain frequencies, which are described below:
Very common | Affect more than 1 in 10 patients |
Common | Affect between 1 and 10 in 100 patients |
Uncommon | Affect between 1 and 10 in 1,000 patients |
Rare | Affect between 1 and 10 in 10,000 patients |
Very rare | Affect less than 1 in 10,000 patients |
Frequency not known | Cannot be estimated from the available data |
Some side effects may be serious. If you notice any of them, tell your doctor immediately:
Rare:
- Signs of allergy such as itching, pruritus, or blisters on the skin; swelling of the face.
Very rare:
- Seizures.
Frequency not known:
- The skin or the whites of the eyes turn yellow, urine darkens, and nausea, vomiting, and fatigue appear (signs of jaundice or hepatitis).
Other side effects:
Very common:
- Increased appetite, weight gain.
Common:
- Drowsiness, fatigue, dizziness, dry mouth, nausea.
Uncommon:
- Constipation.
Rare:
- Depression, excitability, hallucinations (hearing, seeing, or feeling things that are not real), difficulty sleeping, anxiety, tingling and numbness in hands and feet, muscle pain.
Frequency not known:
- Muscle cramps.
If you experience side effects, talk to your doctor or pharmacist, even if it is a side effect not listed in this leaflet.
5. Storage of Mosegor
- Keep out of the reach and sight of children.
- Do not use this medicine after the expiry date stated on the carton. The expiry date is the last day of the month stated.
- No special storage conditions are required.
- Do not use this medicine if you notice visible signs of deterioration.
- Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
6. Contents of the pack and further information
Composition of Mosegor
- The active substance is pizotifen. Each 10 ml of solution contains 0.5 mg of pizotifen.
- The other ingredients are: propyl parahydroxybenzoate (E216), methyl parahydroxybenzoate (E218), citric acid, disodium hydrogen phosphate, ethanol 96%, sucrose, sorbitol 70%, raspberry flavor, maraschino flavor, and purified water.
Appearance of the product and pack contents
Bottle with 200 ml and dosing cup.
Marketing authorization holder
ETHYX PHARMACEUTICALS
19 rue Duquesne
69006 Lyon
France
Manufacturer
DELPHARM ORLEANS
5 avenue de concyr
45071 Orleans
France
This leaflet was approved in
May 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
Illustrative image Image: AEMPS – CIMA - Country of registration
- Dosage formORAL SOLUTION/SUSPENSION, 0.25 mg pizotifen
- ATC codeN02CX01
- Active substance
- Prescription requiredNo
- Manufacturer
- CompositionALCOHOL ETILICO (ETANOL) (100 mg mg), METILPARABENO (E 218) (1,67 mg mg), SOLUCION DE SORBITOL 70% (2500 mg mg), SACAROSA (1500 mg mg), FOSFATO DISODICO (9,79 mg mg), PROPILPARABENO (E 216) (0,84 mg mg)
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MOSEGOR 0.5 mg/10 ml ORAL SOLUTION
AIMOVIG 140 mg SOLUTION FOR INJECTION IN A PRE-FILLED PENIllustrative imageDosage form: INJECTABLE, 140 mgActive substance: erenumabManufacturer: Novartis Europharm LimitedPrescription required
AIMOVIG 70 mg SOLUTION FOR INJECTION IN A PRE-FILLED PENIllustrative imageDosage form: INJECTABLE, 70 mgActive substance: erenumabManufacturer: Novartis Europharm LimitedPrescription requiredAJOVY 225 mg PRE-FILLED SYRINGE SOLUTION FOR INJECTIONIllustrative imageDosage form: INJECTABLE, 225 mgActive substance: fremanezumabManufacturer: Teva GmbhPrescription required
Online doctors for MOSEGOR 0.5 mg/10 ml ORAL SOLUTION
Discuss questions about MOSEGOR 0.5 mg/10 ml ORAL SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.
Frequently Asked Questions
MOSEGOR 0.5 mg/10 ml ORAL SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in MOSEGOR 0.5 mg/10 ml ORAL SOLUTION is pizotifen. This information helps identify medicines with the same composition but different brand names.
MOSEGOR 0.5 mg/10 ml ORAL SOLUTION is manufactured by Ethyx Pharmaceuticals. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Psychiatrists, Neurologists, General medicine doctors, Pain medicine doctors, Anaesthesiologists may assess whether MOSEGOR 0.5 mg/10 ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
The prescription is issued by a doctor after assessing your health. In Spain, MOSEGOR 0.5 mg/10 ml ORAL SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.
To request an assessment, you can use Oladoctor:
Other medicines with the same active substance (pizotifen) include AIMOVIG 140 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AIMOVIG 70 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AJOVY 225 mg PRE-FILLED SYRINGE SOLUTION FOR INJECTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
